Advertisement

Veritas Legal Advised Glenmark Pharmaceuticals Limited In Relation To Sale Of Certain Dermatology Brands

The total consideration in the deal is approximately INR 340 crore (USD 41.66 mn).

Veritas Legal | BW Legal World

Practice Area(s): Corporate / M&ASector(s) Pharma & Healthcare

Date of Announcement: 17 January 2022

Completion Date: 17 January 2022

Name of the Client: Glenmark Pharmaceuticals Limited

Counterparty: Eris Lifesciences Limited

Deal Description: Sale by Glenmark Pharmaceuticals Limited of certain dermatology brands (in India and Nepal) to Eris Lifesciences Limited.

Role of the Firm: Veritas Legal acted for and advised Glenmark Pharmaceuticals Limited in relation to the sale of certain dermatology brands (in India and Nepal) to Eris Lifesciences Limited.

Total Consideration: Approximately INR 340 crore (USD 41.66 mn)

Concerned Partners: Tushar Raut, Natasha Sethna

Concerned Senior Associates & Associates: Karun Jhangiani (Senior Associate), Avadhoot Potnis (Associate), Nishtha Goyal (Associate)

Other related Legal Advisors: Khaitan & Co. acted for Eris Lifesciences Limited


Tags assigned to this article:

Around The World

Advertisement